RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330

Shiwei Zhou,Obinna N. Obianom,Jiangsheng Huang,Dong Guo,Hong Yang,Qing Li,Yan Shu
DOI: https://doi.org/10.3390/pharmaceutics15061623
IF: 6.525
2023-05-31
Pharmaceutics
Abstract:The authors and the journal retract the article, 'Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation' [...]
pharmacology & pharmacy
What problem does this paper attempt to address?